 | • レポートコード：QYR9ST05025 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、精神分裂病治療の世界市場について調査・分析し、精神分裂病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（クロザピン、ジプラシドン、リスペリドン、ルラシドン、パリペリドン）、用途別（病院、クリニック、外来手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の精神分裂病治療市場動向 ・主要企業別マーケットシェア ・精神分裂病治療の種類別市場規模2014-2019 （クロザピン、ジプラシドン、リスペリドン、ルラシドン、パリペリドン） ・精神分裂病治療の用途別市場規模2014-2019 （病院、クリニック、外来手術センター） ・精神分裂病治療の北米市場：主要企業・種類別/用途別市場規模 ・精神分裂病治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・精神分裂病治療の中国市場：主要企業・種類別/用途別市場規模 ・精神分裂病治療の日本国内市場：主要企業・種類別/用途別市場規模 ・精神分裂病治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・精神分裂病治療のインド市場：主要企業・種類別/用途別市場規模 ・精神分裂病治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Eli Lilly、Johnson and Johnson、Pfizer、Astrazeneca、Bristol-Myers Squibb） ・精神分裂病治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality.The mainstay of schizophrenia treatment is antipsychotic medication, along with counselling, job training and social rehabilitation.
In 2018, the global Schizophrenia Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Schizophrenia Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Schizophrenia Therapeutic development in United States, Europe and China.
The key players covered in this study
Eli Lilly
Johnson and Johnson
Pfizer
Astrazeneca
Bristol-Myers Squibb
…
Market segment by Type, the product can be split into
Clozapine
Ziprasidone
Risperidone
Lurasidone
Paliperidone
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Schizophrenia Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the Schizophrenia Therapeutic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Schizophrenia Therapeutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Schizophrenia Therapeutic Market Size Growth Rate by Type (2014-2025)
1.4.2 Clozapine
1.4.3 Ziprasidone
1.4.4 Risperidone
1.4.5 Lurasidone
1.4.6 Paliperidone
1.5 Market by Application
1.5.1 Global Schizophrenia Therapeutic Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Schizophrenia Therapeutic Market Size
2.2 Schizophrenia Therapeutic Growth Trends by Regions
2.2.1 Schizophrenia Therapeutic Market Size by Regions (2014-2025)
2.2.2 Schizophrenia Therapeutic Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Schizophrenia Therapeutic Market Size by Manufacturers
3.1.1 Global Schizophrenia Therapeutic Revenue by Manufacturers (2014-2019)
3.1.2 Global Schizophrenia Therapeutic Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Schizophrenia Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2 Schizophrenia Therapeutic Key Players Head office and Area Served
3.3 Key Players Schizophrenia Therapeutic Product/Solution/Service
3.4 Date of Enter into Schizophrenia Therapeutic Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Schizophrenia Therapeutic Market Size by Type (2014-2019)
4.2 Global Schizophrenia Therapeutic Market Size by Application (2014-2019)
5 United States
5.1 United States Schizophrenia Therapeutic Market Size (2014-2019)
5.2 Schizophrenia Therapeutic Key Players in United States
5.3 United States Schizophrenia Therapeutic Market Size by Type
5.4 United States Schizophrenia Therapeutic Market Size by Application
6 Europe
6.1 Europe Schizophrenia Therapeutic Market Size (2014-2019)
6.2 Schizophrenia Therapeutic Key Players in Europe
6.3 Europe Schizophrenia Therapeutic Market Size by Type
6.4 Europe Schizophrenia Therapeutic Market Size by Application
7 China
7.1 China Schizophrenia Therapeutic Market Size (2014-2019)
7.2 Schizophrenia Therapeutic Key Players in China
7.3 China Schizophrenia Therapeutic Market Size by Type
7.4 China Schizophrenia Therapeutic Market Size by Application
8 Japan
8.1 Japan Schizophrenia Therapeutic Market Size (2014-2019)
8.2 Schizophrenia Therapeutic Key Players in Japan
8.3 Japan Schizophrenia Therapeutic Market Size by Type
8.4 Japan Schizophrenia Therapeutic Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Schizophrenia Therapeutic Market Size (2014-2019)
9.2 Schizophrenia Therapeutic Key Players in Southeast Asia
9.3 Southeast Asia Schizophrenia Therapeutic Market Size by Type
9.4 Southeast Asia Schizophrenia Therapeutic Market Size by Application
10 India
10.1 India Schizophrenia Therapeutic Market Size (2014-2019)
10.2 Schizophrenia Therapeutic Key Players in India
10.3 India Schizophrenia Therapeutic Market Size by Type
10.4 India Schizophrenia Therapeutic Market Size by Application
11 Central & South America
11.1 Central & South America Schizophrenia Therapeutic Market Size (2014-2019)
11.2 Schizophrenia Therapeutic Key Players in Central & South America
11.3 Central & South America Schizophrenia Therapeutic Market Size by Type
11.4 Central & South America Schizophrenia Therapeutic Market Size by Application
12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Schizophrenia Therapeutic Introduction
12.1.4 Eli Lilly Revenue in Schizophrenia Therapeutic Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Johnson and Johnson
12.2.1 Johnson and Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Schizophrenia Therapeutic Introduction
12.2.4 Johnson and Johnson Revenue in Schizophrenia Therapeutic Business (2014-2019)
12.2.5 Johnson and Johnson Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Schizophrenia Therapeutic Introduction
12.3.4 Pfizer Revenue in Schizophrenia Therapeutic Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Astrazeneca
12.4.1 Astrazeneca Company Details
12.4.2 Company Description and Business Overview
12.4.3 Schizophrenia Therapeutic Introduction
12.4.4 Astrazeneca Revenue in Schizophrenia Therapeutic Business (2014-2019)
12.4.5 Astrazeneca Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Schizophrenia Therapeutic Introduction
12.5.4 Bristol-Myers Squibb Revenue in Schizophrenia Therapeutic Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Schizophrenia Therapeutic Key Market Segments
Table Key Players Schizophrenia Therapeutic Covered
Table Global Schizophrenia Therapeutic Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Schizophrenia Therapeutic Market Size Market Share by Type 2014-2025
Figure Clozapine Figures
Table Key Players of Clozapine
Figure Ziprasidone Figures
Table Key Players of Ziprasidone
Figure Risperidone Figures
Table Key Players of Risperidone
Figure Lurasidone Figures
Table Key Players of Lurasidone
Figure Paliperidone Figures
Table Key Players of Paliperidone
Table Global Schizophrenia Therapeutic Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Schizophrenia Therapeutic Report Years Considered
Table Global Schizophrenia Therapeutic Market Size 2014-2025 (Million US$)
Figure Global Schizophrenia Therapeutic Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Schizophrenia Therapeutic Market Size by Regions 2014-2025 (Million US$)
Table Global Schizophrenia Therapeutic Market Size by Regions 2014-2019 (Million US$)
Table Global Schizophrenia Therapeutic Market Share by Regions 2014-2019
Figure Global Schizophrenia Therapeutic Market Share by Regions 2014-2019
Figure Global Schizophrenia Therapeutic Market Share by Regions 2019
Table Market Top Trends
Table Global Schizophrenia Therapeutic Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Schizophrenia Therapeutic Market Share by Manufacturers (2014-2019)
Figure Global Schizophrenia Therapeutic Market Share by Manufacturers in 2018
Table Global Schizophrenia Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Schizophrenia Therapeutic Product/Solution/Service
Table Date of Enter into Schizophrenia Therapeutic Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Schizophrenia Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Global Schizophrenia Therapeutic Market Size Share by Type (2014-2019)
Figure Global Schizophrenia Therapeutic Market Size Market Share by Type (2014-2019)
Table Global Schizophrenia Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Global Schizophrenia Therapeutic Market Size Share by Application (2014-2019)
Figure Global Schizophrenia Therapeutic Market Size Market Share by Application (2014-2019)
Figure Global Schizophrenia Therapeutic Revenue Market Share by Application in 2018
Figure United States Schizophrenia Therapeutic Market Size 2014-2019 (Million US$)
Table United States Key Players Schizophrenia Therapeutic Revenue (2018-2019) (Million US$)
Table United States Key Players Schizophrenia Therapeutic Market Share (2018-2019)
Table United States Schizophrenia Therapeutic Market Size by Type (2014-2019) (Million US$)
Table United States Schizophrenia Therapeutic Market Share by Type (2014-2019)
Table United States Schizophrenia Therapeutic Market Size by Application (2014-2019) (Million US$)
Table United States Schizophrenia Therapeutic Market Share by Application (2014-2019)
Figure Europe Schizophrenia Therapeutic Market Size 2014-2019 (Million US$)
Table Europe Key Players Schizophrenia Therapeutic Revenue (2018-2019) (Million US$)
Table Europe Key Players Schizophrenia Therapeutic Market Share (2018-2019)
Table Europe Schizophrenia Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Europe Schizophrenia Therapeutic Market Share by Type (2014-2019)
Table Europe Schizophrenia Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Europe Schizophrenia Therapeutic Market Share by Application (2014-2019)
Figure China Schizophrenia Therapeutic Market Size 2014-2019 (Million US$)
Table China Key Players Schizophrenia Therapeutic Revenue (2018-2019) (Million US$)
Table China Key Players Schizophrenia Therapeutic Market Share (2018-2019)
Table China Schizophrenia Therapeutic Market Size by Type (2014-20189) (Million US$)
Table China Schizophrenia Therapeutic Market Share by Type (2014-2019)
Table China Schizophrenia Therapeutic Market Size by Application (2014-2019) (Million US$)
Table China Schizophrenia Therapeutic Market Share by Application (2014-2019)
Figure Japan Schizophrenia Therapeutic Market Size 2014-2019 (Million US$)
Table Japan Key Players Schizophrenia Therapeutic Revenue (2018-2019) (Million US$)
Table Japan Key Players Schizophrenia Therapeutic Market Share (2018-2019)
Table Japan Schizophrenia Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Japan Schizophrenia Therapeutic Market Share by Type (2014-2019)
Table Japan Schizophrenia Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Japan Schizophrenia Therapeutic Market Share by Application (2014-2019)
Figure Southeast Asia Schizophrenia Therapeutic Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Schizophrenia Therapeutic Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Schizophrenia Therapeutic Market Share (2018-2019)
Table Southeast Asia Schizophrenia Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Schizophrenia Therapeutic Market Share by Type (2014-2019)
Table Southeast Asia Schizophrenia Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Schizophrenia Therapeutic Market Share by Application (2014-2019)
Figure India Schizophrenia Therapeutic Market Size 2014-2019 (Million US$)
Table India Key Players Schizophrenia Therapeutic Revenue (2018-2019) (Million US$)
Table India Key Players Schizophrenia Therapeutic Market Share (2018-2019)
Table India Schizophrenia Therapeutic Market Size by Type (2014-2019) (Million US$)
Table India Schizophrenia Therapeutic Market Share by Type (2014-2019)
Table India Schizophrenia Therapeutic Market Size by Application (2014-2019) (Million US$)
Table India Schizophrenia Therapeutic Market Share by Application (2014-2019)
Figure Central & South America Schizophrenia Therapeutic Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Schizophrenia Therapeutic Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Schizophrenia Therapeutic Market Share (2018-2019)
Table Central & South America Schizophrenia Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Central & South America Schizophrenia Therapeutic Market Share by Type (2014-2019)
Table Central & South America Schizophrenia Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Central & South America Schizophrenia Therapeutic Market Share by Application (2014-2019)
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Schizophrenia Therapeutic Business (2014-2019) (Million US$)
Figure Eli Lilly Revenue Growth Rate in Schizophrenia Therapeutic Business (2014-2019)
Table Eli Lilly Recent Development
Table Johnson and Johnson Company Details
Table Johnson and Johnson Revenue in Schizophrenia Therapeutic Business (2014-2019)(Million US$)
Figure Johnson and Johnson Revenue Growth Rate in Schizophrenia Therapeutic Business (2014-2019)
Table Johnson and Johnson Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Schizophrenia Therapeutic Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Schizophrenia Therapeutic Business (2014-2019)
Table Pfizer Recent Development
Table Astrazeneca Company Details
Table Astrazeneca Revenue in Schizophrenia Therapeutic Business (2014-2019)(Million US$)
Figure Astrazeneca Revenue Growth Rate in Schizophrenia Therapeutic Business (2014-2019)
Table Astrazeneca Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Schizophrenia Therapeutic Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Schizophrenia Therapeutic Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Global Schizophrenia Therapeutic Market Size by Regions (Million US$) 2019-2025
Figure Global Schizophrenia Therapeutic Market Size Share by Regions (2019-2025)
Figure Global Schizophrenia Therapeutic Market Size Share by Regions in 2025
Figure United States Schizophrenia Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Europe Schizophrenia Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure China Schizophrenia Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Japan Schizophrenia Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Schizophrenia Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure India Schizophrenia Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Schizophrenia Therapeutic Market Size Forecast (2019-2025)(Million USD)
Table Global Schizophrenia Therapeutic Market Size by Product (2019-2025) (Million US$)
Figure Global Schizophrenia Therapeutic Market Size by Product (2019-2025)
Figure Global Schizophrenia Therapeutic Market Size by Product in 2025
Table Global Schizophrenia Therapeutic Market Size by Application (2019-2025) (Million US$)
Figure Global Schizophrenia Therapeutic Market Size by Application (2019-2025)
Figure Global Schizophrenia Therapeutic Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
精神分裂病治療の世界市場：市場規模・現状・予測 Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality.The mainstay of schizophrenia treatment is antipsychotic medication, along with counselling, job training and social rehabilitation. In 2018, the global Schizophrenia Therapeutic market size was x…- 精神分裂病治療法の世界市場：市場規模・現状・予測 Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.The second-generation antipsychotic drugs segment accounted for the majority market shares because these dr…
- 精神分裂病治療法の世界市場：市場規模・現状・予測 Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.The second-generation antipsychotic drugs segment accounted for the majority market shares because these dr…
- 蛆虫治療薬の世界市場：市場規模・現状・予測 Maggot therapy is a type of biotherapy involving the introduction of live, disinfected maggots (fly larvae) into the non-healing skin and soft tissue wound(s) of a human or animal for the purpose of cleaning out the necrotic (dead) tissue within a wound (debridement) and disinfection.North America i…
- 治療用血漿交換の世界市場：市場規模・現状・予測 Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely…